SMAD4 has been implicated in inflammation and hypercoagulation in ischemic stroke, has been associated with BBB disruption and in our previous study was up-regulated in IS participants who later developed hemorrhagic transformation [39]. Here, SMAD4 is linked to ischemic stroke.